Detailed information for compound 1842300

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 330.693 | Formula: C13H10ClF3N4O
  • H donors: 0 H acceptors: 4 LogP: 3.67 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=CN(c1nc(C)nc(n1)C(F)(F)F)Cc1ccc(cc1)Cl
  • InChi: 1S/C13H10ClF3N4O/c1-8-18-11(13(15,16)17)20-12(19-8)21(7-22)6-9-2-4-10(14)5-3-9/h2-5,7H,6H2,1H3
  • InChiKey: GDILJKGSBANGRH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Spinacia oleracea Cytochrome b6-f complex subunit 4 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis dna polymerase eta 0.0034 0.0939 0.0572
Plasmodium vivax cytochrome b 0.0076 0.4755 0.5
Leishmania major DNA polymerase eta, putative 0.0034 0.0939 1
Plasmodium falciparum cytochrome b 0.0076 0.4755 0.5
Toxoplasma gondii apocytochrome b, putative 0.0076 0.4755 1
Entamoeba histolytica ubiquitin carboxyl-terminal hydrolase domain containing protein 0.0028 0.0389 0.5
Loa Loa (eye worm) hypothetical protein 0.0034 0.0939 0.126
Schistosoma mansoni hypothetical protein 0.0133 1 1
Echinococcus granulosus cytochrome B 0.0076 0.4755 0.4543
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0028 0.0389 0.4145
Trichomonas vaginalis conserved hypothetical protein 0.0028 0.0389 0.5
Trichomonas vaginalis Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase 0.0028 0.0389 0.5
Wolbachia endosymbiont of Brugia malayi cytochrome b subunit of the bc complex 0.0076 0.4755 0.5
Brugia malayi ImpB/MucB/SamB family protein 0.0034 0.0939 0.126
Toxoplasma gondii cytochrome b 0.0076 0.4755 1
Trichomonas vaginalis Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase 0.0028 0.0389 0.5
Schistosoma mansoni cytochrome b 0.0076 0.4755 0.4543
Leishmania major ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative 0.0028 0.0389 0.4145
Trypanosoma brucei DNA polymerase eta, putative 0.0034 0.0939 1
Loa Loa (eye worm) cytochrome b 0.0076 0.4755 1
Schistosoma mansoni hypothetical protein 0.0133 1 1
Echinococcus multilocularis geminin 0.0133 1 1
Brugia malayi cytochrome b 0.0076 0.4755 1
Schistosoma mansoni DNA polymerase eta 0.0034 0.0939 0.0572
Echinococcus granulosus dna polymerase eta 0.0034 0.0939 0.0572
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0028 0.0389 0.4145
Trypanosoma cruzi DNA polymerase eta, putative 0.0034 0.0939 1
Giardia lamblia Ubiquitin carboxyl-terminal hydrolase 4 0.0028 0.0389 0.5
Schistosoma mansoni cytochrome b 0.0076 0.4755 0.4543

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 7.01 Inhibition of photosynthetic electron transport in Spinacia oleracea leaf thylakoids assessed as oxygen formation ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.